Dr. Shruti Bhat- Leader Pharmaceutical R&D.
Research Expertise -
Launched -
Generic VALACYCLOVIR tablets FIRST time in CANADA,
MELOXICAM , HYDROCHLOROTHIAZIDE , BISOPROLOL+ HCTZ generic tablets FIRST time in US
AMOXICILLIN + POTASSIUM CLAVULANATE dispersible tablets and scores of formulations FIRST in Brazil, CIS, S.Africa and India.
Four drug anti TB "Forecox tablets" launched first time in the world.
Responsible for the creation of first ever EASY ID labels for products in the CANADIAN market.
Developed the break-through product, FORECOX tablets – 4 drug anti- TB combination, launched FIRST TIME in the WORLD.
900 galenical formulations, 18 different types of dosage forms, 35 different disease areas, CMC expertise for 45 countries across the world.
Biotech and Peptide products.
Statistical Optimization Experimental Designs.
Quality-by-Design (QbD) click to view more.
Bio-Pharmaceutical Classification System (BCS).
Trouble Shooting and Process control.
ICH- Quality Risk Assessment and Analysis.
Dissolution Efficiency techniques to improve bio-availability of poorly soluble drugs.
